Capgemini is in a market-leading or near-dominating position in key markets. Click here to read more about CGEMY stock and why it is rated as a Buy.

Discover HSIC's growth potential with strong Q1 earnings, bullish trends, revamped sales strategies, and ongoing buybacks.

Q1 2025 Earnings Call Transcript May 16, 2025 Operator: Good day, and welcome to the Beam Global First Quarter 2025 Operating ...

Q1 2025 Earnings Call Transcript May 15, 2025 Fluent, Inc. beats earnings expectations. Reported EPS is $-0.31, expectations ...

Cleveland Clinic reported an operating income of $52.8 million (1.3% margin) in the first quarter, up slightly from $50.2 million (1.3% margin) in the same period last year, according to financial ...

Angel One, once a top beneficiary of India's retail investing boom, is now facing headwinds due to tighter SEBI regulations ...

SAN DIEGO, May 15, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM ), (the "Company”), a leading provider of innovative ...

McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, ...

Management targets JPY 65 billion-JPY 75 billion in capital expenditure per year over the medium term. We think its operating cash flow could support such a level of investments, but the dividend ...

Cheltenham-headquartered Spirax Group has said it maintains its outlook for 2025 while recognising that the evolving broader ...

Shares of Spirax Group fell more than 5% on Wednesday after the British manufacturing firm reported a slightly lower four-month profit margin as some customers moved their order shipments to later ...